Anzeige
❌
Mehr »
Freitag, 30.10.2026 - Börsentäglich über 12.000 News
US-Bann naht: Pentagon sperrt China-Metalle - dieser Nickel-Explorer reagiert
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
IB

WKN: A41VMR | ISIN: US36151G7097 | Ticker-Symbol: 12Q
NASDAQ
29.10.26 | 20:59
1,800 US-Dollar
-1,64 % -0,030
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.10.INTELLIGENT BIO SOLUTIONS INC. - 10-K/A, Annual Report8
13.10.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report6
11.09.Intelligent Bio Solutions meldet höhere Aktienzahl nach Ausübung von Optionsscheinen2
10.09.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET2
09.09.Intelligent Bio Solutions submits FDA application for codeine test1
09.09.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report-
09.09.Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market2
09.09.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance296NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln
04.09.Intelligent Bio Solutions Secures Up To $15 Million Private Placement4
01.09.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission239NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
28.08.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report3
20.08.Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M5
19.08.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
19.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth 453Reader installed base grew 22% year-over-year, driving a 35% increase in total consumable cartridges to over 100,000 units Full year gross profit margin expanded to 48.63%, up 778 basis points year-over-year...
► Artikel lesen
19.08.INTELLIGENT BIO SOLUTIONS INC. - 10-K, Annual Report3
17.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification284NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
11.08.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report5
11.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System4
05.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission223NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
03.08.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1